Related news from
Sat, 25 Jul 2026 22:11:58 +0000	Is Cencora (COR) Still Trading At A Discount As Its P E Rerating Gains Pace? Recent screening for stocks with rising P/E ratios and consistent price gains relative to the S&P 500 has put Cencora (COR) in focus for investors tracking valuation and earnings expectations. See our latest analysis for Cencora. Cencora’s recent screening attention comes after a generally mixed year for the share price, with a 30 day share price return of 8.94% contrasting with a year to date decline of 8.55% and a 1 year total shareholder return of 7.53%. This suggests longer term holders...
Sat, 25 Jul 2026 19:09:07 +0000	Cencora (COR) Stock Looks Undervalued As Its 167% Five Year Return Builds Cencora stock has delivered a strong 167.1% return over the past 5 years, yet its current valuation still screens as cheap. An intrinsic value estimate from a Discounted Cash Flow (DCF) model suggests the shares trade at a meaningful discount to that estimate, while market multiples also lean toward an undervalued verdict. A 167.1% total return over 5 years sets a high bar for Cencora. Any hint that cash flow growth slows or that returns on capital plateau may make the current valuation...
Fri, 24 Jul 2026 15:47:00 +0000	HCA Q2 Earnings Beat on Strong Admissions, 2026 Outlook Revised HCA tops Q2 EPS estimates on higher admissions and revenue per admission but trims parts of its 2026 guidance as higher expenses and weaker surgical volumes weigh on results.
Fri, 24 Jul 2026 15:09:00 +0000	Here's Why You Should Add Cencora Stock to Your Portfolio Now COR's specialty expansion, supply-chain investments and international momentum support growth, though pricing, debt and regulation pose risks.
Fri, 24 Jul 2026 12:04:00 +0000	Zacks.com featured highlights include AIM ImmunoTech, Hasbro, Fox, Cencora and Intuitive Surgical AIM, HAS, FOX, COR and ISRG make the list of stocks with rising P/E ratios, a screen highlighting companies investors may view as having stronger earnings potential.
Thu, 23 Jul 2026 18:07:00 +0000	MOH Q2 Earnings Beat on Lower Operating Expenses, 2026 EPS View Raised Molina beats Q2 earnings estimates as lower operating expenses offset weaker premium revenues, declining membership and softer investment income, while the company raises its 2026 earnings guidance.
Thu, 23 Jul 2026 12:25:00 +0000	Bet on 5 Top-Ranked Stocks With Rising P/E Tap five stocks with increasing P/E ratios to try out an out-of-the-box approach.
Fri, 17 Jul 2026 13:42:48 +0000	Cencora Earnings Preview: What to Expect Cencora is scheduled to release its third-quarter results next month, with analysts projecting single-digit earnings growth.
Mon, 13 Jul 2026 21:58:39 +0000	Health Insurance Providers Stocks Q1 In Review: Cencora (NYSE:COR) Vs Peers Earnings results often indicate what direction a company will take in the months ahead. With Q1 behind us, let’s have a look at Cencora (NYSE:COR) and its peers.
Thu, 09 Jul 2026 18:21:00 +0000	Should You Retain CAH Stock After Removal From Several Russell Indices? CAH's Russell index removal reflects reclassification after its share rally, while specialty growth and resilient operations continue supporting its long-term outlook.
Thu, 09 Jul 2026 13:24:35 +0000	McKesson Stock Is Shrinking, and That's The Point for Owners While the market debates growth, this healthcare giant is steadily retiring its own shares, a strategy that has quietly compounded value for investors.
Thu, 09 Jul 2026 08:05:00 +0000	3 Market-Beating Stocks for Long-Term Investors Companies that consistently increase their sales, margins, or returns on capital are usually rewarded with the best returns, and those that can do all three for years on end are almost always the legendary stocks that return 100 times your money.
Wed, 08 Jul 2026 18:24:21 +0000	McKesson Stock Is Shrinking, And That's The Point While the market debates the future of drug pricing, this healthcare giant is steadily handing a larger piece of the business back to its owners.
Mon, 06 Jul 2026 17:29:01 +0000	Eli Lilly and vs. Teva: Which Pharmaceutical Stock Is a Better Buy in 2026? Growth premium vs. value recovery, one trades at 33x forward earnings while the other navigates debt reduction and biosimilar expansion.
Sat, 04 Jul 2026 14:20:48 +0000	Jim Cramer on Cardinal Health: “It’s Been a Real Stalwart, and I Don’t Think It’s Done” Cardinal Health, Inc. (NYSE:CAH) was among the stocks Jim Cramer commented on as he advised investors on how to take advantage of Wednesday’s market rotation. Cramer said that the stock deserves to “trade higher,” as he commented: Can I call your attention to what may be the best one in this group? I’m talking about […]
Wed, 01 Jul 2026 20:30:00 +0000	Cencora Announces Date and Time for Third Quarter Fiscal 2026 Earnings Release CONSHOHOCKEN, Pa., July 01, 2026--Cencora, Inc. (NYSE: COR) today announced that it plans to release its results for the Third Quarter of Fiscal 2026 on Wednesday, August 5, 2026, prior to the opening of trading on the New York Stock Exchange. The Company will host a conference call to discuss the results at 8:30 a.m. ET on August 5, 2026.
Tue, 30 Jun 2026 13:41:46 +0000	Cencora Pick of the Week at Smart Insider Following Chairman's Share Purchase Cencora (COR) was Smart Insider's stock pick of the week after Chair Mark Durcan bought $1 million i
Mon, 29 Jun 2026 19:30:29 +0000	Is McKesson Corporation (MCK) A Good Stock To Buy Now? Is MCK a good stock to buy? We came across a bullish thesis on McKesson Corporation on r/ValueInvesting by OnTheStreetwithLou. In this article, we will summarize the bulls’ thesis on MCK. McKesson Corporation’s share was trading at $763.91 as of June 23rd. MCK’s trailing and forward P/E were 19.41 and 16.81 respectively according to Yahoo Finance. McKesson […]
Mon, 29 Jun 2026 11:07:50 +0000	Cencora (COR) Stock After Recent Pullback And DCF Valuation Gap If you are wondering whether Cencora stock is priced for opportunity or already reflects its strengths, the current setup invites a closer look at what investors are really paying for. Cencora shares last closed at US$286.13, with the stock up 5.5% over the past week and 6.2% over the past month, while still showing a 15.6% decline year to date and a 3.9% decline over the past year. These shorter term moves sit alongside a longer 3 year return of 53.8% and a 5 year return of 158.3%. This...
Sun, 28 Jun 2026 18:05:52 +0000	Cencora (COR) Launches Nucleus Pilot As Verizon Executive Joins As CHRO Cencora (NYSE:COR) has launched a multi-site pilot of its upgraded Nucleus inventory management solution for specialty physician practices. The pilot focuses on improving medication workflow efficiency and inventory visibility across participating sites. The company has appointed Samantha Hammock, formerly of Verizon, as Chief Human Resources Officer, succeeding Silvana Battaglia. These developments reflect operational and leadership changes that may affect Cencora's specialty care...

If you are already a Value Forum member but are not logged on, click here to log on. If you are a guest, thank you for visiting ValueForum -- click here for information about guest access or click here to join -- a Trial Pass can be purchased for $6.99 to help you decide if you want to commit to longer term membership. Did you know there are customized portals into VF like REITs.ValueForum.com and also My ValueForum which lets you customize your VF experience to the posters and topics that most interest you!